Author:
Alexander Sarah W.,Mueller Brigitta U.,Pizzo Philip A.
Reference219 articles.
1. Schibler KR, Osborne KA, Leung LY, Le TV, Baker SI, Thompson DD: A randomized, placebo-controlled trial of granulocyte colony-stimulating factor administration to newborn infants with neutropenia and clinical signs of early-onset sepsis. Pediatrics 102:6–13, 1998.
2. Cairo MS, Agosti J, Ellis R, et al: A randomized, double-blind, placebo-controlled trial of prophylactic recombinant human granulocyte-macrophage colony-stimulating factor to reduce nosocomial infections in very low birth weight neonates. J Pediatr 134:64–70, 1999.
3. Reed MD, Besunder JB: Developmental pharmacology: Ontogenic basis of drug disposition. Pediatr Clin North Am 36:1053–1074, 1989.
4. Committee on Drugs: Unapproved uses of approved drugs: The physician, the package insert, and the Food and Drug Administration: Subject review. Pediatrics 98:143–145, 1996.
5. Kauffman RE: Status of drug approval processes and regulation of medications for children. Curr Opin Pediatr 7:195–198, 1995.
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Infections in the Immunocompromised;Advances in Experimental Medicine and Biology;2009-10-24